✦ LIBER ✦

(210) Results from a phase I, double-blind, randomized, placebo-controlled, multiple-dose study evaluating the safety, tolerability, and pharmacokinetics of oral doses of NKTR-118

✍ Scribed by D. Sahner; H. van Paaschen; A. Marcantonio; M. Eldon

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

737 A PHASE-I, RANDOMIZED, DOUBLE-BLIND,

✍ U. Lopatin; G. Wolfgang; R. Kimberlin; D. Turnas; M. Cornprost; G. Chittick; C. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 46 KB

A phase I/II randomized, double-blind, p

✍ AK Gupta; C Leonardi; RR Stoltz; PF Pierce; B Conetta; the Ravuconazole onychomy 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB

A randomized, double-blind, placebo-cont

✍ Yuji Kumagai; Tomoko Hasunuma; Desmond Padhi 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 697 KB

162 A RANDOMIZED DOUBLE-BLIND, PLACEBO-C

✍ P. Jochelson; J.L. van de Wetering; J. Bornstein; M. Resler; K. Anderson 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 39 KB

Efficacy and Safety of Darusentan in Pat

✍ Henry R. Black; George L. Bakris; Michael A. Weber; Robert Weiss; Mahfouz El Sha 📂 Article 📅 2007 🏛 Le Jacq Communications, Inc. 🌐 English ⚖ 246 KB

Tolerability and pharmacokinetics of ava

✍ Jinah Jung; Sangmin Choi; Sang Heon Cho; Jong-Lyul Ghim; Aekyung Hwang; Unjib Ki 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 128 KB